Posted on 19/05/2017Evenings at the Florey - major depression and bipolar disorder
In this presentation Professor Michael Berk asks the question - can supplements change the way we think about mental health treatments such as major depression and bipolar disorder?
Prof Berk is currently leading a Deakin University study in the Geelong area, of a drug used to treat paracetamol overdoses. He aims to gauge its effectiveness in helping debilitating bipolar depression. It is hoped the treatment will effectively provide the brains of people with bipolar with a vital energy boost. Prof Berk believes that bipolar disorder appears to be a condition which mainly relates to energy levels.
Prof Michael Berk - Florey Honorary Professorial Research Fellow in the Department of Psychiatry
Professor Michael Berk is currently a NHMRC Senior Principal Research Fellow and is Alfred Deakin Chair of Psychiatry at Deakin University, where he heads the IMPACT Strategic Research Centre. He also is an Honorary Professorial Research Fellow in the Department of Psychiatry, the Florey Institute for Neuroscience and Mental Health and Orygen Youth Health at Melbourne University, as well as in the School of Public Health and Preventive Medicine at Monash University. Professor Berk is past president of the International Society for Bipolar Disorders and the Australasian Society for Bipolar and Depressive Disorders. He has published over 500 papers predominantly in mood disorders. His major interests are in the discovery and implementation of novel therapies, and risk factors and prevention of psychiatric disorders.
The lecture will begin promptly at 6.30pm and finsh at approximately 7.45pm.